My survival is based on research. With limited NIH funding, I fear that my life, and the lives of others, will be left without hope.” ...

Q4 2024 Earnings Call Transcript March 13, 2025 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is ...

MS patients on anti-CD20 therapies are significantly less likely to discontinue treatment than those given other DMTs, a ...

Researchers have found a new way to more precisely detect and monitor brain cell activity during deep brain stimulation, a common treatment for movement disorders such as Parkinson's disease and ...

A Long Island hospital has successfully treated Sebastien Beauzile, a 21-year-old from Laurelton, with the groundbreaking ...

There are three main types of ovarian cancer: epithelial, germ cell, and stromal. Learn about each type’s defining ...

A multi-site study, backed by an $8 million NIH grant, will evaluate the effectiveness of Lucid Diagnostics' EsoCheck and ...

A stem cell therapy trial aimed at reducing neuroinflammation in patients with presymptomatic Alzheimer's disease is underway at UTHealth Houston.

Parkinson's cases are set to double by 2050. Learn why it's rising and how lifestyle changes can support long-term brain ...

Data on the number of cases for these diseases from the pre-vaccine era is hard to come by, and even the case counts are ...

Learn the essential early warning signs of leukemia that are often dismissed as everyday ailments but could be indicators of ...

In humans and other multicellular organisms, cells multiply. This defining feature allows embryos to grow into adulthood, and ...